Overview of growth differentiation factor 15 in metabolic syndrome

Growth and differentiation factor 15 (GDF15) is a member of the transforming growth factor‐β (TGF‐β) superfamily. GDF15 has been linked with several metabolic syndrome pathologies such as obesity and cardiovascular diseases. GDF15 is considered to be a metabolic regulator, although its precise mecha...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular and molecular medicine Vol. 27; no. 9; pp. 1157 - 1167
Main Authors Asrih, Mohamed, Wei, Shibo, Nguyen, Thanh T., Yi, Hyon‐Seung, Ryu, Dongryeol, Gariani, Karim
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.05.2023
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN1582-1838
1582-4934
1582-4934
DOI10.1111/jcmm.17725

Cover

Loading…
More Information
Summary:Growth and differentiation factor 15 (GDF15) is a member of the transforming growth factor‐β (TGF‐β) superfamily. GDF15 has been linked with several metabolic syndrome pathologies such as obesity and cardiovascular diseases. GDF15 is considered to be a metabolic regulator, although its precise mechanisms of action remain to be determined. Glial cell‐derived neurotrophic factor family receptor alpha‐like (GRAL), located in the hindbrain, has been identified as the receptor for GDF15 and signals through the coreceptor receptor tyrosine kinase (RET). Administration of GDF15 analogues in preclinical studies using various animal models has consistently been shown to induce weight loss through a reduction in food intake. GDF15, therefore, represents an attractive target to combat the current global obesity epidemic. In this article, we review current knowledge on GDF15 and its involvement in metabolic syndrome.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1582-1838
1582-4934
1582-4934
DOI:10.1111/jcmm.17725